1987
DOI: 10.1016/s0161-6420(87)33325-1
|View full text |Cite
|
Sign up to set email alerts
|

Intravitreal Liposome-encapsulated Triofluorothymidine in a Rabbet Model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
8
0

Year Published

1988
1988
2016
2016

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 28 publications
(9 citation statements)
references
References 30 publications
1
8
0
Order By: Relevance
“…The therapeutic effect of the drug\ x=req-\ containing implant was associated with sustained intravitreal concentrations of fluorouracil between 1 and 13 mg/L for at least 14 days, and fluorouracil concentrations remained above 0.3 \g=m\g/mL for almost 21 …”
mentioning
confidence: 99%
“…The therapeutic effect of the drug\ x=req-\ containing implant was associated with sustained intravitreal concentrations of fluorouracil between 1 and 13 mg/L for at least 14 days, and fluorouracil concentrations remained above 0.3 \g=m\g/mL for almost 21 …”
mentioning
confidence: 99%
“…In a preliminary study in our laboratory [9], intravitreally injected drug-free liposomes were found to be nontoxic by histopathological and electrophysiological studies. These may imply that liposomes, as a vehicle, are not only nontoxic but also can reduce the toxic side effects of encapsulated drugs.…”
Section: Discussionmentioning
confidence: 97%
“…This contributes to prevention of peak concentration, and maintains the therapeutic drug level for a longer period of time. Preliminary work in our laboratory [5,9,16,18] and by other investigators [2,20,22] has demonstrated that intravitreally administered liposome-encapsulated drugs have potential in effective drug delivery for various ocular diseases.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations